Healthcare -
Biotechnology - NASDAQ - US
$ 2.405
-2.63 %
$ 366 M
Market Cap
-26.72
P/E
HRTX - REVENUE
Revenue HRTX - Heron Therapeutics, Inc.
127 M
LAST VALUE
21.30%
2 YEAR CAGR
10.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR